Dergiler / Turkish Computational and Theoretical Chemistry / 2026 / Volume: 10 Issue: 2

COMPUTATIONAL INVESTIGATION OF THE EFFECT OF LICHEN METABOLITES ON THE INHIBITION OF EPIDERMAL GROWTH FACTOR RESEPTOR L858R MUTATION

Özlem Alamoody(ÜSKÜDAR ÜNİVERSİTESİ, FEN BİLİMLERİ ENSTİTÜSÜ)0009-0001-1178-2242
Ahmed Ali Mohamed Al-amoody(ÜSKÜDAR ÜNİVERSİTESİ, FEN BİLİMLERİ ENSTİTÜSÜ)0000-0003-0448-3778
Çiğdem Sezer Zhmurov(ÜSKÜDAR ÜNİVERSİTESİ, FEN BİLİMLERİ ENSTİTÜSÜ)0000-0002-8423-5063
Vildan Atalay(ISTANBUL TECHNICAL UNIVERSITY, INSTITUTE OF INFORMATICS, DEPARTMENT OF COMPUTATIONAL SCIENCE AND ENGINEERING)0000-0002-9830-9158
Sayfa
—
Yayın Tarihi
2026-05-17
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

BIOVIA Discovery Studio program was used for the docking images between protein and molecule.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Epidermal growth factor reseptör (EGFR) is an important protein in the cell cycle; mutations in the protein cause many problems.
📊
Temel Bulgular & Veri:One of the most common mutations in the EGFR protein is the L858R mutation in exon 21, which is a type of missense single nucleotide polymorphism (SNP).
💡
Sonuç & Katkı:BIOVIA Discovery Studio program was used for the docking images between protein and molecule.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:EGFR · Molecular · Protein

Abstract

Epidermal growth factor reseptör (EGFR) is an important protein in the cell cycle; mutations in the protein cause many problems. The vast majority of these diseases manifest themselves as tumours. One of the most common mutations in the EGFR protein is the L858R mutation in exon 21, which is a type of missense single nucleotide polymorphism (SNP). In this mutation, the leucine in the 858th amino acid of the protein changes to arginine, and the thymine nucleotide in the leucine structure changes to guanine nucleotide. This nucleotide change leads to a high rate of cancer. Lung cancers are the leading cause of cancer caused by L858R mutations. Especially the L858R mutation is the leading cause of non-small cell lung cancer (NSCLC), and this type of mutation has been detected in most patients with this type of cancer. In this study, a docking study was conducted to determine molecules that could be inhibitors for the mutant EGFR molecule, and lichen secondary metabolites were used for this purpose. While as known there are more than 400 lichen secondary metabolites, 155 molecules were selected as examples for this study. For this purpose, geometry optimizations were performed with the semi-empirical PM6 method on the most stable structure obtained after conformer analysis of the active molecules that have an effect from the selected lichen secondary metabolites, and a QSAR model was created to correlate the docking energies of the relevant molecules and their physicochemical properties. Optimizations and docking operations were performed in Spartan’14 and Autodock Vina programs, respectively. Calculations made for all studied molecule types, results of physicochemical parameters and linear regression analyses between binding energies were performed with the Excel program. BIOVIA Discovery Studio program was used for the docking images between protein and molecule.

🔖

Bu Makaleye Atıf Yap

Alamoody, Ö., Al-amoody, A. A. M., Zhmurov, Ç. S., Atalay, V. (2026). COMPUTATIONAL INVESTIGATION OF THE EFFECT OF LICHEN METABOLITES ON THE INHIBITION OF EPIDERMAL GROWTH FACTOR RESEPTOR L858R MUTATION. Turkish Computational and Theoretical Chemistry, Volume: 10 Issue: 2. https://doi.org/10.33435/tcandtc.1632731

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (20)

  1. W.S. Klug, M. R. Cummings, Genetik Kavramlar, (Çev. Öner,C.), Palme Yayıncılık (2003).
  2. H. M. Christoffersen, (2020), Gene Mutations: Causes and Effects (2020), New York: Nova Medicine and Health.
  3. N. A. Campbell, J. B. Reece. Biyoloji. (Çeviri Editörleri: Gündüz, E., Demirsoy A., Türkan İ.) Ankara: Palme Yayıncılık, (2008).
  4. B. Bütüner-Debeleç, G. Kantarcı, Mutasyon, Dna Hasarı, Onarım Mekanizmaları Ve Kanserle İlişkisi, Ankara Ecz Fak Dergisi: (2006) 35 (2) 149 – 170.
  5. NIH, National Cancer Instutue, 2024.
  6. https://genemania.org/search/homo-sapiens/egfr/
  7. https://string-db.org/cgi/network?taskId=bWv3g4qvpLtw&sessionId=bpNL6cnMp1u5
  8. A. Franceschini, D. Szklarczyk, S. Frankild, M. Kuhn, M. Simonovic, A. Roth, L. J. Jensen, STRING v9. 1: protein-protein interaction networks, with increased coverage and integration, Nucleic acids research, (2012) 41(D1), D808-D815
  9. N. Normanno, A. De Luca, C. Bianco, L. Strizzi, M. Mancino, M. R. Maiello, A. Carotenuto, G. De Feo, F. Caponigro, D. S. Salomon, Epidermal growth factor receptor (EGFR) signaling in cancer, Gene, (2006) Volume 366, Issue 1, Pages 2-16.
  10. https://cancer.sanger.ac.uk/cosmic/search?q=egfr
  11. J.Y Liu, S. Z. Wang, H. Q. Yuan, J. L. Li, P. Y. Xing, Patients with non small cell lung cancer with the exon 21 L858R mutation: From distinct mechanisms to epidermal growth factor receptor tyrosine kinase inhibitor treatments (Review). Oncol Lett, (2024) 29(3):109.
  12. https://www.uniprot.org/
  13. https://alphafold.ebi.ac.uk/
  14. A. Christopher, L. Franco, W. Dominy Beryl, J. Feeney Paul, Lipinski: Advanced drug delivery reviews. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, (1997) 23(1-3). 3-25.
  15. G.M. Morris, R. Huey, W. Lindstrom, M. F. Sanner, R. K. Belew, D.S. Goodsell, A.J. Olson, AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. (2009) Dec;30(16):2785-91.
  16. J. Eberhardt, D. Santos-Martins, A.F. Tillack, S. Forli, AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings, J Chem Inf Model, (2021) 61(8):3891-3898.
  17. Biovia, Dassault Systemes %J San Diego: Dassault Systèmes. Discovery Studio Visualizer v21. 1.0. 20298 (2024).
  18. Biovia, Dassault Systemes %J San Diego: Dassault Systèmes. Discovery Studio Visualizer v21. 1.0. 20298 (2021).
  19. A. A. Al-Amoody, D. Yayman, T. Kaan, E.A. Özkök, A. Özcan, E. Özen, E., G. Çobanoğlu Özyiğitoğlu, Role of lichen secondary metabolites and pigments in UV-screening phenomenon in lichens, Acta Biologica Turcica, (2020) 33(1): 35-48.
  20. G. Çobanoğlu Özyiğitoğlu, B. Açıkgöz, C. Sesal. Lichen secondary metabolites: Synthesis pathways and biological activities. Acta Biologica Turcica, 29.4 (2017) 150-163.